NCT01127321: A Safety and Tolerability Study of MEDI-570 in Systemic Lupus Erythematosus |
|
|
| Terminated | 1 | 44 | US, Canada, RoW | Placebo, MEDI-570 0.03 MG, MEDI-570 0.1 MG, MEDI-570 0.3 MG, MEDI-570 1 MG | MedImmune LLC, AstraZeneca | Lupus Erythematosus, Systemic | 07/12 | 07/12 | | |
